Misoprostol: discovery, development, and clinical applications

Medicinal Research Reviews
P W Collins

Abstract

Misoprostol is a synthetic 15-deoxy-16-hydroxy-16-methyl analog of PGE1, and the first prostaglandin to be registered for the treatment of peptic ulcer disease. Misoprostol is a safe and well-tolerated drug that exerts potent gastric antisecretory effects and mucosal protective actions on the gastric and duodenal mucosa. In a dosage of 800 micrograms daily in two or four divided doses, misoprostol produced rates of complete ulcer healing in both gastric and duodenal ulcer patients significantly superior to placebo and comparable to H2 receptor antagonists. The major adverse effect is diarrhea in about 10% of patients, but this is usually mild and self-limiting. Misoprostol possesses uterotonic activity and should not be used in pregnant women or those who wish to become pregnant. Misoprostol effectively heals and prevents NSAID-induced gastropathy, a therapeutic need previously unserved. Due to its mucosal protective properties, misoprostol may have advantages over antisecretory drugs in the compromised patient who is a chronic smoker or alcohol user, in refractory duodenal ulcer patients, in recurrent ulcer, and in emergency use for acute upper GI bleeding. Misoprostol's tissue-protective effects may also extend to other thera...Continue Reading

References

Jan 1, 1978·Acta Obstetricia Et Gynecologica Scandinavica·J R Dingfelder, W E Brenner
Dec 1, 1976·The American Journal of Digestive Diseases·E Z DajaniR Pappo
Sep 1, 1977·Journal of Medicinal Chemistry·P W CollinsR Pappo
Feb 19, 1975·Journal of the American Chemical Society·C J SihG Peruzzotti
Feb 19, 1975·Journal of the American Chemical Society·C J SihS S Lee
Jan 1, 1985·Gastroenterology·G M AndersonD J Cohen
Jun 4, 1988·Lancet
Jan 1, 1988·Scandinavian Journal of Gastroenterology. Supplement·J J Misiewicz
Dec 1, 1985·Digestive Diseases and Sciences·D R Johnson
Jan 1, 1988·Journal of Clinical Gastroenterology·G L Eastwood
Feb 1, 1986·Digestive Diseases and Sciences·D E WilsonM Noar
Feb 1, 1986·Digestive Diseases and Sciences·J I IsenbergM A Koss
Feb 1, 1986·Digestive Diseases and Sciences·F E SilversteinD S Levine
Feb 1, 1986·Digestive Diseases and Sciences·R L Herting, C H Nissen
Jul 1, 1986·Journal of Medicinal Chemistry·P W CollinsR G Bianchi
Jan 1, 1987·Journal of Medicinal Chemistry·P W CollinsR F Bauer
Jul 27, 1987·The American Journal of Medicine·E D CorboyE A Swabb
Jan 1, 1987·Prostaglandins·P W CollinsR F Bauer
Jan 1, 1987·Prostaglandins·G Watkinson, F A Akbar
Jan 1, 1988·Scandinavian Journal of Gastroenterology. Supplement·G J CleghornT L Holt
Jan 1, 1988·Toxicologic Pathology·K L Schmidt, T A Miller
Jun 1, 1988·Drug Intelligence & Clinical Pharmacy·R L KleimanK S Ephgrave
Jan 1, 1988·Postgraduate Medical Journal·K ParkA K Li
Jan 1, 1987·Prostaglandins·W R Hanson, K DeLaurentiis
Apr 1, 1986·Journal of Medicinal Chemistry·P W Collins

❮ Previous
Next ❯

Citations

Oct 28, 1998·American Journal of Obstetrics and Gynecology·A A BamigboyeD A Merrell
Mar 27, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·P A le RouxC H Rodeck
Sep 16, 2003·Best Practice & Research. Clinical Obstetrics & Gynaecology·Thomas F Baskett
Oct 26, 1999·The Journal of Obstetrics and Gynaecology Research·K M DiabM A Yehia
Feb 4, 2006·BMJ : British Medical Journal·Jodie M DoddJeffrey S Robinson
May 1, 1991·Postgraduate Medical Journal·P N BennettC E Lee
Dec 27, 1996·European Journal of Obstetrics, Gynecology, and Reproductive Biology·D JannetJ Milliez
May 1, 1994·Kidney International·S NatovT P Hannedouche
Jan 5, 2011·Taiwanese Journal of Obstetrics & Gynecology·Shi-Yann ChengShu-Chen Pei
Dec 28, 2010·Journal de gynécologie, obstétrique et biologie de la reproduction·L GitzE Barranger
Sep 24, 2005·Reproductive Biomedicine Online·Chinmoy K Bose
Jul 21, 2009·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Mahmoud ShokryOmar M Shaaban
Aug 17, 2005·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·E BarcaiteR Nadisauskiene
Aug 20, 2005·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·A BartuseviciusR Nadisauskiene
Jun 1, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·David J BraydenEdwin Walsh
Mar 31, 2015·Social Science & Medicine·Colin MillardAllyson Pollock
Jun 6, 2006·Acta Cirúrgica Brasileira·Míriam Elias CavalliniMarina Raquel Araújo
Jul 17, 2004·Acta Obstetricia Et Gynecologica Scandinavica·Claudio CelentanoSigi Rotmensch
Jun 1, 1996·Clinical Obstetrics and Gynecology·S Murray, K Muse
Feb 15, 1995·European Journal of Biochemistry·A SchmidH Dinter
Sep 26, 2000·BJOG : an International Journal of Obstetrics and Gynaecology·H El-RefaeyC Rodeck
Oct 8, 1998·British Journal of Obstetrics and Gynaecology·A Templeton
Oct 16, 1999·British Journal of Obstetrics and Gynaecology·F AmantF A Van Assche
Mar 1, 1997·British Journal of Obstetrics and Gynaecology·H el-RefaeyC Rodeck
Sep 11, 1999·Obstetrical & Gynecological Survey·H C ScheepersA S van den Bergh
Mar 1, 1995·British Journal of Sports Medicine·G Florida-James, T Reilly
Dec 1, 1990·Prostaglandins, Leukotrienes, and Essential Fatty Acids·D J FretlandT S Gaginella
Jun 23, 2021·The Cochrane Database of Systematic Reviews·Robbie S KerrAndrew D Weeks

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Obstetrics and Gynaecology Research
Nawarat PaungmoraPiyaporn Punyavachira
International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
Umran Küçükgöz GüleçSelim Buyukkurt
European Journal of Obstetrics, Gynecology, and Reproductive Biology
S Ginath, H V Zakut
© 2021 Meta ULC. All rights reserved